Skip to main content

Table 1 Baseline characteristics of the South Asian and White European populations

From: Cardio-metabolic outcomes in South Asians compared to White Europeans in the United Kingdom: a matched controlled population-based cohort study

Characteristic

South Asian

(n = 94,870)

White

(n = 189,740)

Male, n (%)

49,795 (52.49)

99,594 (52.49)

Age, years, median (IQR)

41 (35 to 53)

41 (35 to 52)

BMI, mean (SD)

26.2 (4.8)

26.8 (5.6)

BMI category, n (%)

 18.5–25 kg/m2

35,963 (37.91)

68,996 (36.36)

 25–30 kg/m2

31,909 (33.63)

56,424 (29.74)

 > 30 kg/m2

14,878 (15.68)

37,736 (19.89)

 Missing

12,120 (12.78)

26,584 (14.01)

Smoking, n (%)

 Smoker

11,656 (12.29)

52,526 (27.68)

 Ex-smoker

8459 (8.92)

40,761 (21.48)

 Non-smoker

72,551 (76.47)

91,884 (48.43)

 Missing

2204 (2.32)

4569 (2.41)

Townsend, n (%)

 1

10,490 (11.06)

22,496 (11.86)

 2

10,682 (11.26)

23,429 (12.35)

 3

17,959 (18.93)

35,916 (18.93)

 4

20,575 (21.69)

38,745 (20.42)

 5

16,069 (16.94)

30,186 (15.91)

 Missing

19,095 (20.13)

38,968 (20.54)

Lipid profile

 Total cholesterol (mean (SD))

4.9 (1.05)

5.1 (1.01)

 Triglycerides (median (IQR))

1.4 (1 to 1.96)

1.3 (0.9 to 1.89)

 HDL (mean (SD))

1.26 (0.35)

1.4 (0.42)

Blood pressure, (mean, (SD))

 Systolic

124.1 (16.15)

126.5 (15.6)

 Diastolic

76.7 (9.9)

77.57 (9.8)

Comorbidities, n (%)

 Type 2 diabetes

11,487 (12.11)

8052 (4.24)

 Hypertension

14,306 (15.08)

22,670 (11.95)

 IHD

4135 (4.36)

5061 (2.6)

 Stroke or TIA

1283 (1.35)

2812 (1.48)

 Heart failure

562 (0.59)

837 (0.44)

 Atrial fibrillation

457 (0.48)

1824 (0.96)

Medication, n (%)

 Lipid-lowering drugs

16,311 (17.19)

20,608 (10.86)